Generic Name: Ranibizumab injection
Brand Name: Lucentis
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Indications: Macular edema, secondary to retinal vein occlusion
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: October 18, 2012
Recommendation Type: List with clinical criteria and/or conditions